Chronic Escherichia coli infection induces muscle wasting without changing acetylcholine receptor numbers

Intensive Care Medicine

Volumn 34, Issue 3, 2008, Pages 561-567

  Frick, Christiane G ^a,b   Fink, Heidrun ^b   Gordan, Maria L ^b   Eckel, Barbara ^b   Martyn, J A Jeevendra ^a   Blobner, Manfred ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acetylcholine receptors; Critical Illness; Infection; Inflammation; Muscle contraction

Indexed keywords

ACUTE PHASE PROTEIN; BUNGAROTOXIN; IODINE 125; NICOTINIC RECEPTOR; OROSOMUCOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; ENTEROBACTER INFECTION; INFLAMMATION; MALE; MUSCLE ATROPHY; MUSCLE FORCE; MUSCLE MASS; MUSCLE TETANIC CONTRACTION; MUSCLE TONE; MUSCLE WEAKNESS; MYOGRAPHY; NEUROMUSCULAR FUNCTION; NONHUMAN; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SEPSIS; SPRAGUE DAWLEY RAT; WEIGHT REDUCTION;

ACUTE-PHASE PROTEINS; ANIMALS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; MALE; MUSCLES; MUSCULAR ATROPHY; NEUROMUSCULAR JUNCTION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WEIGHT LOSS;

EID: 43049112447     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0852-3     Document Type: Article

References (37)

1. Bolton CF (2005) Neuromuscular manifestations of critical illness. Muscle Nerve 32:140-163
2. Zochodne DW, Bolton CF (1996) Neuromuscular disorders in critical illness. Baillieres Clin Neurol 5:645-671
3. Bolton CF (1993) Neuromuscular complications of sepsis. Intensive Care Med Suppl 19(2):S58-S63
4. Bednarík J, Vondracek P, Dusek L, Moravcova E, Cundrle I (2005) Risk factors for critical illness polyneuromyopathy. J Neurol 252:343-351
5. Johnson KL (2007) Neuromuscular complications in the intensive care unit: critical illness polyneuromyopathy. AACN Adv Crit Care 18:167-180
6. Rannou F, Pennec JP, Rossignol B, Morel J, Dorange G, Arvieux C, Gioux M, Giroux-Metges MA (2007) Effects of chronic sepsis on rat motor units: experimental study of critical illness polyneuromyopathy. Exp Neurol 204:741-747
7. De Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, van der Meche FG (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29:2281-2286
8. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H, Bastuji-Garin S (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288:2859-2867
9. Hund E (2001) Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 248:929-934
10. Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH, Hinds CJ (2003) Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 31:1012-1016
11. Visser LH (2006) Critical Illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur J Neurol 13:1203-1212
12. Bolton CF (1996) Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 24:1408-1416
13. Sieck GC, Prakash YS (1995) Fatigue at the neuromuscular junction. Branch point vs. presynaptic vs. postsynaptic mechanisms. Adv Exp Med Biol 384:83-100
14. Coakley JH, Nagendran K, Hanover M (1993) Neuromuscular abnormalities in the critical ill. Intensive Care Med 19:323-328
15. Ibebunjo C, Martyn JA (1999) Fiber atrophy, but not changes in acetylcholine receptor expression, contributes to the muscle dysfunction after immobilization. Crit Care Med 27:275-285
16. Breuille D, Voisin L, Contrepois M, Arnal M, Rose F, Obled C (1999) A sustained rat model for studying the long-lasting catabolic state of sepsis. Infect Immun 67:1079-1085
17. Fink MP, Heard SO (1990) Laboratory models of sepsis and septic shock. J Surg Res 49:186-196
18. Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res 29:189-201
19. Metzger J, Blobner M, Luppa PB (2001) Sensitive chemiluminescence immunoassay for the determination of rat serum alpha1-acid glycoprotein. Clin Chem Lab Med 39:514-518
20. Breuille D, Rose F, Arnal M, Melin C, Obled C (1994) Sepsis modifies the contribution of different organs to whole-body protein synthesis in rats. Clin Sci (Lond) 86:663-669
21. Andrews P, Azoulay E, Antonelli M, Brochard L, Brun-Buisson C, De Backer D, Dobb G, Fagon JY, Gerlach H, Groeneveld J, Macrae D, Mancebo J, Metnitz P, Nava S, Pugin J, Pinsky M, Radermacher P, Richard C (2005) Year in review in intensive care medicine. I. Experimental studies. Clinical studies: brain injury, renal failure and endocrinology. Intensive Care Med 33:49-57
22. Fink H, Luppa P, Mayer B, Rosenbrock H, Metzger J, Martyn JA, Blobner M (2003) Systemic inflammation leads to resistance to atracurium without increasing membrane expression of acetylcholine receptors. Anesthesiology 98:82-88
23. Cooney RN, Kimball SR, Vary TC (1997) Regulation of skeletal muscle protein turnover during sepsis: mechanisms and mediators. Shock 7:1-16
24. Voisin L, Breuille D, Combaret L, Pouyet C, Taillandier D, Aurousseau E, Obled C, Attaix D (1996) Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+-activated, and ubiquitin-proteasome proteolytic pathways. J Clin Invest 97:1610-1617
25. Rennie MJ, Edwards RH, Emery PW, Halliday D, Lundholm K, Millward DJ (1983) Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexia. Clin Physiol 3:387-398
26. Vary TC, Kimball SR (1992) Regulation of hepatic protein synthesis in chronic inflammation and sepsis. Am J Physiol 262:C445-C452
27. Clowes GH Jr, George BC, Villee CA Jr, Saravis CA (1983) Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med 308:545-552
28. Hasselgren PO, Talamini M, James JH, Fischer JE (1986) Protein metabolism in different types of skeletal muscle during early and late sepsis in rats. Arch Surg 121:918-923
29. Ibebunjo C, Martyn J (2001) Disparate dysfunction of skeletal muscles located near and distant from burn site in the rat. Muscle Nerve 24:1283-1294
30. Blobner M, Kochs E, Fink H, Mayer B, Veihelmann A, Brill T, Stadler J (1999) Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: treatment with NG-monomethyl-L-arginine. Anesthesiology 91:999-1005
31. Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM (1992) Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 76:822-843
32. Tomera JF, Martyn J (1989) Intraperitoneal endotoxin but not protein malnutrition shifts d-tubocurarine dose-response curves in mouse gastrocnemius muscle. J Pharmacol Exp Ther 250:216-220
33. Martyn JA, Richtsfeld M (2006) Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 104:158-169
34. Vincent A, Newland C, Croxen R, Beeson D (1997) Genes at the junction-candidates for congenital myasthenic syndromes. Trends Neurosci 20:15-22
35. Kohlschutter B, Baur H, Roth F (1976) Suxamethonium-induced hyperkalaemia in patients with severe intra-abdominal infections. Br J Anaesth 48:557-562
36. Gronert GA (1999) Succinylcholine hyperkalemia after burns. Anesthesiology 91:320-322
37. Tsukagoshi H, Morita T, Takahashi K, Kunimoto F, Goto F (1999) Cecal ligation and puncture peritonitis model shows decreased nicotinic acetylcholine receptor numbers in rat muscle: immunopathologic mechanisms? Anesthesiology 91:448-460